White Mulberry Leaf Benefits

Most herbs arrive with a long list of benefits and a short list of explanations. White mulberry leaf — Morus alba L., Moraceae, 桑葉 sāng yè in Chinese medicine, lá dâu tằm in Vietnam — is the reverse. It has essentially one benefit that stands on solid mechanistic ground, and that one benefit is understood down to the enzyme.

The molecule is 1-deoxynojirimycin, usually shortened to DNJ. It is an iminosugar: a molecule built like glucose but with a nitrogen atom where glucose has an oxygen. That swap lets it jam the α-glucosidase enzymes on the wall of your small intestine — the enzymes that perform the last cut on starch and table sugar before the sugar can be absorbed. Block them and carbohydrate arrives in the bloodstream slower and flatter. This is the identical target of three prescription drugs, and one of them, miglitol, is chemically a derivative of DNJ itself.

Everything useful about mulberry leaf, and every problem with it, falls out of that single fact. It only works taken with the carbohydrate — a capsule swallowed at bedtime does nothing for tomorrow’s lunch. Its side effects are acarbose’s side effects, for the same reason: undigested carbohydrate reaches the colon, bacteria ferment it, and you get gas, bloating and loose stools. And it adds to prescription glucose-lowering drugs, which is a real interaction, not a disclaimer.

One consequence deserves stating on the front page, because it is a safety issue rather than an efficacy one: if you are at risk of hypoglycaemia and you take an α-glucosidase inhibitor, a hypo must be treated with pure glucose — dextrose tablets or gel — not with juice, sweets, milk or table sugar. The drug is blocking the very enzyme that would break those down. This is standard, non-negotiable advice for anyone on acarbose or miglitol, and by the same mechanism it applies here.

Said plainly: mulberry leaf blunts post-meal glucose spikes. It is not a treatment for diabetes and does not replace one.

Table of Contents

1. Deep-Dive Articles
2. The Mechanism, in One Page
3. Dose by DNJ, Not by Milligrams
4. Evidence Map — What Is Solid and What Is Not
5. The Leaf Is Not the Fruit
6. Safety in Brief
7. Key Research Papers
8. External Resources
9. Connections

Deep-Dive Articles

Four articles go deeper than the main herb page. Start with blood sugar — that is where the evidence lives, and the other three are consequences of it.

The Mechanism, in One Page

Starch and table sugar cannot be absorbed as they are. They have to be cut down to single sugar molecules first, and the last cut happens at the brush border — the microscopically fringed surface of the small-intestinal lining. Enzymes anchored there, known collectively as α-glucosidases (sucrase-isomaltase and maltase-glucoamylase are the two big ones), snip the final bonds. Only then can glucose cross into the blood.

DNJ looks enough like glucose to be accepted into those enzymes’ active sites. But its ring nitrogen carries a positive charge at gut pH, which mimics the fleeting, high-energy transition state the enzyme normally stabilises. The result is that DNJ binds far more tightly than the real sugar does — and cannot be cut. It occupies the site and blocks it. A key machined to fit the lock, with the tip fused solid.

Four things follow directly, and they structure everything else on this page:

1. The glucose curve flattens rather than shrinks. Carbohydrate is delayed, not deleted. Absorption spreads further down the intestine and further out in time. The peak comes down; the total is largely unchanged.
2. Timing is the whole intervention. The enzyme sits in the gut wall; its substrate is the meal. No overlap, no effect. Mulberry leaf does not accumulate and does not work between meals.
3. The side effects are the mechanism made audible. Carbohydrate that escapes the small intestine gets fermented by colonic bacteria into gas and short-chain fatty acids. Bloating, flatulence, rumbling and loose stools are the predictable result. In one careful study using breath-hydrogen measurement, a tea extract containing mulberry caused roughly 25 percent of a carbohydrate meal to be malabsorbed.
4. The drug interactions are predictable, not speculative. Acarbose, miglitol and voglibose hit the same enzyme; combining them is additive in both effect and side effects. Insulin, sulfonylureas and glinides can push glucose down on their own, and mulberry leaf lowers the curve they are dosed against.

Dose by DNJ, Not by Milligrams

This is the single most useful practical idea across the four articles, so it belongs here too.

“500 mg mulberry leaf” on a label tells you almost nothing, because DNJ content in the raw leaf is both low and wildly variable. A Kyoto survey of 276 mulberry cultivars found mean DNJ largely in the 0.04–0.06 percent range and demonstrated that α-glucosidase inhibition tracked DNJ content closely (r = 0.901 in one July harvest) — and that the same cultivar assayed in May, July and August gave measurably different activity. The Japanese group that built a DNJ-enriched food powder reported that commercial mulberry products contained about 0.1 percent DNJ, which is why they had to concentrate the leaf to 1.5 percent before it could deliver a usable dose.

Two independent dose-finding studies converged on the same number.

• Japanese volunteers given 0, 6, 12 or 18 mg of DNJ with 50 g of sucrose showed a dose-related suppression of the glucose rise.
• A Thai dose-finding arm using the same 0/6/12/18 mg ladder concluded that 12 mg of DNJ was the minimum effective dose for attenuating postprandial hyperglycaemia.

So the number to look for on a label is milligrams of DNJ per serving, taken with each carbohydrate-containing meal. If a product does not state DNJ, you cannot connect it to any trial in the literature — and that is not a technicality, it is the whole comparison.

Evidence Map — What Is Solid and What Is Not

The Leaf Is Not the Fruit

Worth repeating because it is the commonest error in consumer writing about this plant. Mulberry fruit is a food and a completely separate topic. It is sweet, perishable, rich in vitamin C and (in dark cultivars) anthocyanins, and in Chinese medicine the dried fruit is its own herb, 桑椹 sāng shèn. It contains no meaningful DNJ.

Eating mulberries does not blunt your post-meal glucose. Dried mulberries are a concentrated sugar source. Nothing in these four articles applies to them — nor to 桑白皮 sāng bái pí, the root bark, which has an entirely different chemistry built on prenylated flavonoids and moracins.

Safety in Brief

The full treatment is in How to Take It. The short version:

• Gastrointestinal effects are common and dose-dependent. In a Thai dyslipidaemia study using mulberry leaf tablets three times daily, 26 percent of participants reported mild diarrhoea. Start low, build over one to two weeks.
• Tell your prescriber if you take any diabetes medication. Not a formality — a supplement that flattens your glucose curve changes the readings your doses are titrated against.
• Carry glucose tablets, not sweets, if you are at risk of hypoglycaemia.
• Avoid concentrated extracts in pregnancy, breastfeeding and childhood. Ordinary leaf tea has centuries of food use; standardised extracts have not been studied in these groups.
• Avoid in inflammatory bowel disease, active IBS flares or bowel obstruction. Deliberately increasing colonic fermentation is a poor idea in an inflamed or obstructed bowel.
• Stop two weeks before scheduled surgery, as with any glucose-affecting supplement.

Key Research Papers

Every PubMed identifier below was checked live against NCBI E-utilities before it was printed — title, first author, journal and year all had to match. Where a claim could not be tied to a confirmed record, it carries a PubMed topic search instead of a number that might point at the wrong paper. Study type is labelled throughout.

Postprandial glucose — the core human evidence

1. Mudra M, Ercan-Fang N, Zhong L, Furne J, Levitt M. Influence of mulberry leaf extract on the blood glucose and breath hydrogen response to ingestion of 75 g sucrose by type 2 diabetic and control subjects. Diabetes Care. 2007;30(5):1272–1274. Human. The study that observed the mechanism instead of inferring it: glucose fell and breath hydrogen rose, confirming carbohydrate reaching the colon.
2. Kimura T, Nakagawa K, Kubota H, Kojima Y, et al. Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans. Journal of Agricultural and Food Chemistry. 2007;55(14):5869–5874. Human, dose-ranging. 0/6/12/18 mg DNJ with 50 g sucrose; also the source of the “commercial products contain ~0.1 percent DNJ” figure.
3. Asai A, Nakagawa K, Higuchi O, Kimura T, et al. Effect of mulberry leaf extract with enriched 1-deoxynojirimycin content on postprandial glycemic control in subjects with impaired glucose metabolism. Journal of Diabetes Investigation. 2011;2(4):318–323. Human. Two studies: an acute crossover in 12 people, then 12 weeks in 76 — postprandial control improved, fasting glucose and HbA1c did not.
4. Lown M, Fuller R, Lightowler H, Fraser A, et al. Mulberry-extract improves glucose tolerance and decreases insulin concentrations in normoglycaemic adults: results of a randomised double-blind placebo-controlled study. PLoS ONE. 2017;12(2):e0172239. Human, n = 37. Clean dose-response against 50 g maltodextrin in people without diabetes.

Longer trials, and the results that were negative

1. Riche DM, Riche KD, East HE, Barrett EK, et al. Impact of mulberry leaf extract on type 2 diabetes (Mul-DM): a randomized, placebo-controlled pilot study. Complementary Therapies in Medicine. 2017;32:105–108. Human, n = 24 (17 completed). Post-meal readings improved; HbA1c did not differ from placebo, and serum creatinine rose 15 percent.
2. Thaipitakwong T, Supasyndh O, Rasmi Y, Aramwit P. A randomized controlled study of dose-finding, efficacy, and safety of mulberry leaves on glycemic profiles in obese persons with borderline diabetes. Complementary Therapies in Medicine. 2020;49:102292. Human. Established 12 mg DNJ as the minimum effective dose; over 12 weeks glucose tolerance did not improve.
3. Cui W, Luo K, Xiao Q, Sun Z, et al. Effect of mulberry leaf or mulberry leaf extract on glycemic traits: a systematic review and meta-analysis. Food & Function. 2023;14(3):1277–1289. Meta-analysis, 12 trials, 615 participants. Small pooled reductions in fasting glucose, HbA1c and fasting insulin.

Lipids and cardiovascular

1. Aramwit P, Petcharat K, Supasyndh O. Efficacy of mulberry leaf tablets in patients with mild dyslipidemia. Phytotherapy Research. 2011;25(3):365–369. Human, n = 23, within-subject — no control group.
2. Kojima Y, Kimura T, Nakagawa K, Asai A, et al. Effects of mulberry leaf extract rich in 1-deoxynojirimycin on blood lipid profiles in humans. Journal of Clinical Biochemistry and Nutrition. 2010;47(2):155–161. Human, n = 10, open-label, single group.
3. Holman RR, Coleman RL, Chan JCN, Chiasson JL, et al. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial. The Lancet Diabetes & Endocrinology. 2017;5(11):877–886. Human, n = 6,522. The class read-across, and it is negative for cardiovascular events.

The drug class: what α-glucosidase inhibition does and does not achieve

1. Chiasson JL, Josse RG, Gomis R, Hanefeld M, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. The Lancet. 2002;359(9323):2072–2077. Human, n = 1,429. Fewer conversions to diabetes — and 31 percent of the acarbose group stopped treatment early.
2. Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, et al. Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. 2005;(2):CD003639. Systematic review, 41 trials, 8,130 participants.
3. Zhong L, Furne JK, Levitt MD. An extract of black, green, and mulberry teas causes malabsorption of carbohydrate but not of triacylglycerol in healthy volunteers. American Journal of Clinical Nutrition. 2006;84(3):551–555. Human. Quantified the malabsorption at roughly 25 percent of the carbohydrate load.

Chemistry, variability and safety

1. Yatsunami K, Ichida M, Onodera S. The relationship between 1-deoxynojirimycin content and alpha-glucosidase inhibitory activity in leaves of 276 mulberry cultivars (Morus spp.) in Kyoto, Japan. Journal of Natural Medicines. 2008;62(1):63–66. Analytical. Why two products at the same milligram dose are not the same product.
2. Chan EW, Lye PY, Wong SK. Phytochemistry, pharmacology, and clinical trials of Morus alba. Chinese Journal of Natural Medicines. 2016;14(1):17–30. Review.
3. Murbach TS, Glávits R, Endres JR, Hirka G, et al. A 90-day preclinical toxicological evaluation in rats of a highly purified and concentrated mulberry leaf extract. Journal of Applied Toxicology. 2024;44(10):1504–1517. Animal. No adverse effects to 2,550 mg/kg/day in rats.
4. Konno K, Ono H, Nakamura M, Tateishi K, et al. Mulberry latex rich in antidiabetic sugar-mimic alkaloids forces dieting on caterpillars. Proceedings of the National Academy of Sciences USA. 2006;103(5):1337–1341. Insect/ecology. DNJ is the tree’s chemical weapon — the reason it exists at all.

Live PubMed Searches

1. Morus alba leaf
2. Mulberry leaf and postprandial glucose
3. 1-Deoxynojirimycin
4. Acarbose and miglitol
5. Mulberry leaf and human lipids
6. Mulberry leaf safety
7. DNJ content by cultivar and season
8. Silkworms and mulberry latex alkaloids

External Resources

• PubChem — 1-deoxynojirimycin compound record
• PubChem — miglitol, the DNJ derivative that became a drug
• LiverTox — NIH database of drug and herbal liver injury
• NCCIH — Herbs at a Glance
• World Flora Online — Morus alba L. taxonomy
• ClinicalTrials.gov — registered mulberry leaf trials

Connections

• All Herbs
• White Mulberry Leaf (Morus alba) — the main herb page: botany, names, forms, full cautions.
• Gymnema — the other classic blood-sugar herb, with a completely different mechanism.
• Bitter Melon — widely used in Asia for blood sugar, with a messier evidence base.
• Berberine — acts on AMPK and the liver rather than on gut enzymes; the two are often confused.
• Type 2 Diabetes — the medical context for everything on this page.

Back to Table of Contents